🇺🇸 MRK — Merck & Co., Inc.
Healthcare CompraPrecio actual
150,33 USD
Máx. histórico
156,92
10 días
Caída desde máximo
-4,20%
Rango 52 semanas
77,58 – 156,92
Variación hoy
-1,32%
Cierre anterior
152,34
Rango de hoy
150,09 – 152,22
Volumen hoy
4.298.143
- Nombre completo
- Merck & Co., Inc.
- Divisa
- USD
- Mercado
- NYSE
- Sector
- Healthcare
- Industria
- Drug Manufacturers - General
- Empleados
- 73.000
- PER ⓘ
- 122,22 (puede no estar actualizado)
- Dividend yield
- 2,23% (puede no estar actualizado)
- Precio objetivo analistas
- 148,73 USD (puede no estar actualizado)
- Primera cotización
- 02/01/1962
- Precio actualizado
- hace 2 días
Merck & Co., Inc. operates as a healthcare company worldwide. It offers human health pharmaceutical for various areas under the Keytruda, Keytruda Qlex, Welireg, Gardasil, ProQuad, M-M-R II, Varivax, Vaxneuvance, Capvaxive, RotaTeq, Pneumovax 23, Bridion, Prevymis, Dificid, Zerbaxa, Winrevair, Adempas/ Verquvo, Ohtuvayre, Lagevrio, Isentress/Isentress HD, Delstrigo, Pifeltro, Belsomra, Januvia, and Janumet brands. The company also provides veterinary pharmaceuticals, vaccines and health management solutions and services, such as livestock products under the Nuflor, Bovilis/Vista, Bovilis Cryptium, Banamine, Estrumate, Matrix, Resflor, Zuprevo, Revalor, Safe-Guard, M+Pac, Porcilis, Circumvent, Nobilis/Innovax, Paracox and Coccivac, Exzolt, Slice, Imvixa, Clynav, Aquavac/Norvax, Aquaflor, Flexolt brands; Allflex Livestock Intelligence solutions; and companion animal products under the Bravecto One-Month, Bravecto Injectable/Quantum, Bravecto TriUNO, Bravecto Plus, Sentinel Spectrum, Sentinel Flavor Tabs, Numelvi, Optimmune, Nobivac NXT, GilvetMab, Otomax, Mometamax, Mometamax Ultra, Posatex, Caninsulin/Vetsulin, Panacur, Safeguard, Regumate, Prestige, Scalibor/Exspot, Sure Petcare, and Home Again brands. It has development and commercialization agreement for three of Daiichi Sankyo's deruxtecan ADC candidates; AstraZeneca PLC to co-development and co-commercialize AstraZeneca's Lynparza products for multiple cancer types; licensed to develop, manufacture and commercialize LM-299, a novel investigational PD-1/VEGF bispecific antibody from LaNova; and collaboration agreement with Eisai Co., Ltd., Bayer AG, and Ridgeback Biotherapeutics LP, as well Moderna, Inc. Merck & Co., Inc. has strategic collaboration with Infinimmune, Inc. to discover and develop antibodies against multiple therapeutic targets. The company was founded in 1891 and is headquartered in Rahway, New Jersey.
| Fecha de pago | Importe por participación |
|---|---|
| 02/12/1992 | 0,1193 USD |
| 31/08/1992 | 0,1193 USD |
| 02/06/1992 | 0,1097 USD |
| 02/03/1992 | 0,1097 USD |
| 02/12/1991 | 0,1002 USD |
| 30/08/1991 | 0,1002 USD |
| 03/06/1991 | 0,0891 USD |
| 04/03/1991 | 0,0891 USD |
| 03/12/1990 | 0,0891 USD |
| 28/08/1990 | 0,0891 USD |
| 29/05/1990 | 0,0716 USD |
| 05/03/1990 | 0,0716 USD |
| 04/12/1989 | 0,0716 USD |
| 29/08/1989 | 0,0716 USD |
| 30/05/1989 | 0,0652 USD |
| Fecha | Apertura | Máximo | Mínimo | Cierre | Variación | Volatilidad día | Volumen |
|---|---|---|---|---|---|---|---|
| 25/01/1979 | 1,78 | 1,83 | 1,78 | 1,83 | +2,42% | 2,42% | 3.599.251 |
| 24/01/1979 | 1,83 | 1,83 | 1,78 | 1,78 | -2,54% | 2,90% | 3.836.938 |
| 23/01/1979 | 1,84 | 1,86 | 1,82 | 1,83 | -0,36% | 2,16% | 2.505.139 |
| 22/01/1979 | 1,85 | 1,85 | 1,83 | 1,84 | -0,72% | 0,89% | 2.524.003 |
| 19/01/1979 | 1,86 | 1,87 | 1,84 | 1,85 | -0,71% | 1,61% | 3.535.114 |
| 18/01/1979 | 1,86 | 1,87 | 1,85 | 1,86 | +0,00% | 1,07% | 1.377.072 |
| 17/01/1979 | 1,86 | 1,86 | 1,84 | 1,86 | +0,00% | 1,42% | 3.157.834 |
| 16/01/1979 | 1,90 | 1,90 | 1,86 | 1,86 | -1,92% | 1,75% | 6.093.072 |
| 15/01/1979 | 1,88 | 1,90 | 1,88 | 1,90 | +1,06% | 1,06% | 6.500.534 |
| 12/01/1979 | 1,88 | 1,90 | 1,88 | 1,88 | +1,25% | 0,88% | 9.175.450 |
| 11/01/1979 | 1,81 | 1,86 | 1,81 | 1,86 | +2,94% | 2,56% | 14.242.320 |
| 10/01/1979 | 1,80 | 1,81 | 1,80 | 1,80 | +0,00% | 0,74% | 2.097.677 |
| 09/01/1979 | 1,80 | 1,81 | 1,80 | 1,80 | +0,00% | 0,73% | 4.391.539 |
| 08/01/1979 | 1,81 | 1,81 | 1,79 | 1,80 | -0,55% | 1,10% | 2.988.058 |
| 05/01/1979 | 1,80 | 1,82 | 1,79 | 1,81 | +0,55% | 1,47% | 3.542.659 |
| 04/01/1979 | 1,81 | 1,84 | 1,80 | 1,80 | -0,18% | 2,20% | 3.655.843 |
| 03/01/1979 | 1,80 | 1,82 | 1,80 | 1,81 | +0,37% | 1,11% | 2.701.325 |
| 02/01/1979 | 1,79 | 1,80 | 1,76 | 1,80 | +0,37% | 2,22% | 2.327.818 |
| 29/12/1978 | 1,80 | 1,81 | 1,79 | 1,79 | -0,18% | 1,11% | 1.312.934 |
| 28/12/1978 | 1,80 | 1,81 | 1,79 | 1,80 | -0,37% | 1,29% | 3.248.381 |
| 27/12/1978 | 1,81 | 1,81 | 1,78 | 1,80 | -1,63% | 2,01% | 3.459.658 |
| 26/12/1978 | 1,81 | 1,84 | 1,80 | 1,83 | +1,28% | 2,20% | 1.822.262 |
| 22/12/1978 | 1,78 | 1,81 | 1,78 | 1,81 | +1,67% | 1,86% | 2.407.046 |
| 21/12/1978 | 1,78 | 1,82 | 1,77 | 1,78 | +0,19% | 2,42% | 4.451.904 |
| 20/12/1978 | 1,69 | 1,78 | 1,69 | 1,78 | +5,51% | 5,31% | 3.780.346 |
| 19/12/1978 | 1,66 | 1,70 | 1,65 | 1,68 | +1,60% | 2,80% | 2.188.224 |
| 18/12/1978 | 1,66 | 1,66 | 1,63 | 1,66 | -1,96% | 2,19% | 2.927.693 |
| 15/12/1978 | 1,71 | 1,71 | 1,69 | 1,69 | -1,16% | 1,16% | 1.863.763 |
| 14/12/1978 | 1,69 | 1,71 | 1,69 | 1,71 | +1,18% | 1,18% | 1.920.355 |
| 13/12/1978 | 1,73 | 1,73 | 1,68 | 1,69 | -2,30% | 2,68% | 4.029.350 |